Correlation Between Elecnor SA and Pharma Mar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elecnor SA and Pharma Mar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elecnor SA and Pharma Mar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elecnor SA and Pharma Mar SA, you can compare the effects of market volatilities on Elecnor SA and Pharma Mar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elecnor SA with a short position of Pharma Mar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elecnor SA and Pharma Mar.

Diversification Opportunities for Elecnor SA and Pharma Mar

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Elecnor and Pharma is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Elecnor SA and Pharma Mar SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharma Mar SA and Elecnor SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elecnor SA are associated (or correlated) with Pharma Mar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharma Mar SA has no effect on the direction of Elecnor SA i.e., Elecnor SA and Pharma Mar go up and down completely randomly.

Pair Corralation between Elecnor SA and Pharma Mar

Assuming the 90 days trading horizon Elecnor SA is expected to generate 6.26 times less return on investment than Pharma Mar. But when comparing it to its historical volatility, Elecnor SA is 4.18 times less risky than Pharma Mar. It trades about 0.16 of its potential returns per unit of risk. Pharma Mar SA is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  4,164  in Pharma Mar SA on September 2, 2024 and sell it today you would earn a total of  3,646  from holding Pharma Mar SA or generate 87.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Elecnor SA  vs.  Pharma Mar SA

 Performance 
       Timeline  
Elecnor SA 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Elecnor SA are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Elecnor SA may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Pharma Mar SA 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Mar SA are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Pharma Mar exhibited solid returns over the last few months and may actually be approaching a breakup point.

Elecnor SA and Pharma Mar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elecnor SA and Pharma Mar

The main advantage of trading using opposite Elecnor SA and Pharma Mar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elecnor SA position performs unexpectedly, Pharma Mar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharma Mar will offset losses from the drop in Pharma Mar's long position.
The idea behind Elecnor SA and Pharma Mar SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account